Bayer chief claims full board backing

Bayer’s management retains the backing of its supervisory board, its chief executive said, after pressure on the company increased when a second jury in the US ruled its glyphosate-based Roundup weed killer caused cancer.

Bayer, which denies allegations that glyphosate or Roundup cause cancer, acquired Monsanto, the maker, for $63bn (€56bn) last year.